Antiangiogenic and antitumoral properties of a polysaccharide isolated from the seaweed Sargassum stenophyllum

Cancer Chemotherapy and Pharmacology

Volumn 56, Issue 4, 2005, Pages 436-446

  Dias, Paulo Fernando ^a   Siqueira Jr , Jarbas Mota ^a   Vendruscolo, Luiz Felipe ^a   Neiva, Teresinha De Jesus ^a   Gagliardi, Antônio Ricardo ^b,c   Maraschin, Marcelo ^a   Ribeiro do Valle, Rosa Maria ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b Centro Universitario Lusiada UNILUS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiogenesis; Angiostatic activity; Antitumoral activity; Polysaccharide; Sargassum stenophyllum

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GELFOAM; HYDROCORTISONE; POLYSACCHARIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTICOAGULATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL VIABILITY; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG MEGADOSE; DRUG POTENTIATION; EMBRYO; IMPLANTATION; MALE; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; SARGASSUM; SEAWEED; SKIN; THROMBIN TIME; TUMOR; ZYGOTE;

EID: 23244434817     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-004-0995-7     Document Type: Article

References (78)

1. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182-1186
2. Folkman J, Shing Y (1992) Control of angiogenesis by heparin and other sulfated polysaccharides. Adv Exp Med Biol 313:355-364
3. Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235:442-447
4. Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenesis switch. Nat Rev Cancer 3:401-410
5. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364
6. Folkman J (1995) Clinical applications of research on angiogenesis. N Engl J Med 333:1757-1763
7. Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345-357
8. Kalluri R (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3:423-433
9. Fachinger G, Deutsch U, Risau W (1999) Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene 18(43):5948-5953
10. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular specific growth factors and blood vessel formation. Nature 407:242-248
11. Solimene ACC, Boscardin SB, Ferraz MGC, Chammas R (1999) Angiogenesis in solid tumors. SBOC 1:9-20
12. Chipperfield H, Kuldip SB, Simon MC, Nurcombe V (2002) Heparan sulfates isolated from adult neural progenitor cells can direct phenotypic maturation. Int J Dev Biol 46:661-670
13. Nugent MA, Iozzo RV (2000) Fibroblast growth factor-2. Int J Biochem Cell Biol 32:115-120
14. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31
15. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D (1991) Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66:1095-1104
16. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257
17. Koch AE (1998) Angiogenesis. Implications for rheumatoid arthritis. Arthritis Rheum 41(6):951-962
18. Jones N, Iljin K, Dumont DJ, Alitalo K (2001) Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2:257-267
19. Crum R, Szabo S, Folkman J (1985) A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230:1375-1378
20. Hlatky L, Folkman F (2002) Clinical application antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 94:883-893
21. Carmeliet P (2003) Angiogenesis in health and disease. Nat Med 9(6):653-660
22. Gagliardi AR, Hadd HE, Collins DC (1992) Inhibition of angiogenesis by suramin. Cancer Res 52:5073-5075
23. Leali D, Belleri M, Urbinati C, Coltrini D, Oreste P, Zoppetti G, Ribatti D, Rusnati M, Presta M (2001) Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. J Biol Chem 276(41):37900-37908
24. Cristofanilli M, Charnsangavej C, Ortobagyi GN (2002) Angiogenesis modulation in cancer research: novel clinical approaches. Nat Rev Drug Discov 1:415-426
25. Koyanagi S, Tanigawa N, Nakagawa H, Soeda S, Shimeno H (2003) Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 65:173-179
26. Tan W, Lin L, Li M, Zhang YX, Tong Y, Xiao D, Ding J (2003) Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential. Eur J Pharmacol 459(2):255-262
27. Chen HH, Zhou HJ, Wang WQ, Wu GD (2004) Antimalarial dihydroartemisin also inhibits angiogenesis. Cancer Chemother Pharmacol 53:423-432
28. Albano RM, Pavao MS, Mourao PA, Mulloy B (1990) Structural studies of a sulfated L-galactan from Styela plicata (Tunicate): analysis of the Smith-degraded polysaccharide. Carbohydr Res 208:163-174
29. Berlinck RG, Ogawa CA, Almeida AM, Sanchez MA, Malpezzi EL, Costa LV, Hajdu E, de Freitas JC (1996) Chemical and pharmacological characterization of halitoxin from Amphimedon viridis (Porifera) from the southeastern Brazilian coast. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 115(2):155-163
30. Mian AJ, Percival E (1973) Carbohydrates of the brown seaweeds Himanthalia lorea and Bifurcaria bifurcata. Structural studies of the "fucans". Carbohydr Res 26:147-156
31. Abdel-Fattah A, Hussein MM-D, Salem HM (1974) Studies of the purification and some properties of sargassan, a sulphated heteropolysaccharide from Sargassum linifolium. Carbohydr Res 33:9-17
32. Nishino T, Yokoyama G, Dobashi K, Fujihara M, Nagumo T (1989) Isolation, purification, and characterization of fucose-containing sulfated polysaccharides from the brown seaweed Ecklonia kurome and their blood-anticoagulant activities. Carbohydr Res 186:119-129
33. Nishino T, Nagumo T (1992) Anticoagulant and antithrombin activities of oversulfated fucans. Carbohydr Res 229:355-362
34. 2 inhibitors from marine algae. Hydrobiologia 260:521-529
35. König GM, Wright AD (1995) Marine natural products research. Current directions and future potential. Planta Med 62:193-211
36. Noda H, Amano H, Arashima K, Hashimoto S, Nisizawa K (1989) Studies on the antitumor activity of marine algae. Nippon Suissan Gakkaishi 55(7):1259-1264
37. Duarte MER, Cardoso MA, Noseda M, Cerezo AS (2001) Structural studies on fucoidans from the brown seaweed Sargassum stenophyllum. Carbohydr Res 333:281-293
38. Grumet M, Flaceus A, Margolis RRU (1993) Functional characterization of chondroitin sulphate proteoglycans of brain: interaction with neuron and neural cell adhesion molecules. J Cell Biol 120(3):815-824
39. Katz BZ, Yamada KM (1997) Integrins in morphogenesis and signaling. Biochimie 79:467-476
40. Selvendran RR, Stevens BJH, O'Neill MA (1985) Developments in the isolation and analysis of cell walls from edible plants. In: Brett CT, Hillman JR (eds) Biochemistry of the plant cell wall, Cambridge University Press, London, pp 39-78
41. Maraschin M, Carobrez SG, Persike D, Peixoto MI, Ferreira AG, Ferracin R, Verpoorter R, Fontana JD (2000) Cell wall polysaccharides from Mandevilla velutina (Apocynaceae) cultured cells: extraction and chemical structure. Carbohydr Polym 41:55-60
42. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
43. Blumenkrantz N, Asboe-Hansen G (1973) New method for quantitative determination of uronic acids. Anal Biochem 54:484-489
44. Gagliardi AR, Collins DC (1993) Inhibition of angiogenesis by antiestrogens. Cancer Res 53:533-535
45. Drabkin DL, Austin JH (1932) Spectrophotometric constants for common haemoglobin derivatives in human, dog, and rabbit blood. J Biol Chem 98:719-722
46. Lee YS, Yang HO, Shin KH, Choi HS, Jung SH, Hoon S, Kim YM, Oh DK, Linhardt RJ, Kim YS (2003) Suppression of tumor growth by a new glycosaminoglycan isolated from the African giant snail Achatina fulica. Eur J Pharmacol 465:191-198
47. Ingber D, Fugita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348:555-557
48. Burke RR (1973) A factor from a transformed cell line that affects cell migration. Proc Natl Acad Sci U S A 70:368-372
49. Igura K, Ohta T, Kuroda Y, Kaji K (2001) Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett 171:11-16
50. Carmichael J, Degraff WG, Gazdar AF, Minn JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47:936-942
51. Carlucci MJ, Pujol CA, Ciancia C, Noseda MD, Matulewicz MC, Damonte EB, Cerezo AS (1997) Antiherpetic and anticoagulant properties of carrageenans from the red seaweed Gigartina skottsbergii and their cyclized derivatives: correlation between structure and biological activity. Int J Biol Macromol 20:97-105
52. Orr SF (1954) Infra-red spectroscopic studies of some polysaccharides. Biochem Biophys Acta 14:173-181
53. Nguyen M, Shing Y, Folkman J (1994) Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc Res 47:31-40
54. Jackson CJ, Giles I, Knop A, Nethery A, Schrieber L (1994) Sulfated polysaccharides are required for collagen-induced vascular tube formation. Exp Cell Res 215:294-302
55. Gallagher JT (1994) Heparan sulphates as membrane receptors for the fibroblast growth factor. Eur J Clin Chem Clin Biochem 32:239-247
56. Dowd CJ, Cooney CL, Nugent MA (1999) Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding. J Biol Chem 274:5236-5244
57. Miao H, Ornitz DM, Aingorn E, Ben-Sasson SA, Vlodavsky I (1997) Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound. J Clin Invest 99:1565-1575
58. Mundhenke C, Meyer K, Drew S, Friedl A (2002) Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol 160:185-194
59. Matou S, Helly D, Chabut D, Bros A, Fischer A-M (2002) Effect of fucoidan on fibroblast growth factor-2-induced angiogenesis in vitro. Thromb Res 106:213-221
60. Soeda S, Kosako T, Iwata K, Shimeno H (2000) Oversulfated fucoidan inhibits the basic fibroblast growth factor-induced tube formation by human umbilical vein endothelial cells: its possible mechanism of action. Biochim Biophys Acta 1497:127-134
61. Coffey RJ Jr, Leof EB, Shipley GD, Moses HL (1987) Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J Cell Physiol 132:143-148
62. Yayon A, Klagsbrun M (1990) Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin. Proc Natl Acad Sci U S A 87:5346-5350
63. Pesenti E, Sol F, Mongelli N, Grandi M, Spreafico F (1992) Suramin prevents neovascularization and tumor growth through blocking of basic fibroblast growth factor activity. Br J Cancer 66:367-374
64. Fairbrother WJ, Champe MA, Christinger HW, Keyt BA, Starovasnik MA (1998) Solution structure of the heparin-binding domain vascular endothelial growth factor. Structure 6:637-648
65. Princivalle M, de Agostini A (2002) Developmental roles of heparan sulfate proteoglycans a comparative review in Drosophila, mouse and human. Int J Dev Biol 46:267-278
66. Dhoot GK, Gustafsson MK, Ai X, Sun W, Standiford DM, Emerson CP Jr (2001) Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science 293:1663-1666
67. Burg MA, Halfter W, Cole GJ (1995) Analysis of proteoglycan expression in developing chicken brain: characterization of a heparan sulfate proteoglycan that interacts with the neural cell adhesion molecule. J Neurosci Res 41:49-64
68. Tobelem G (1990) Endothelial cell growth: biology and pharmacology in relation to angiogenesis. Blood Coagul Fibrinolysis 1:703-705
69. Takaku T, Kimura Y, Okuda H (2001) Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. J Nutr 131:1409-1413
70. Nguyen NM, Leer JE, Pienta KJ (1993) Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo. Anticancer Res 13(6A):2143-2147
71. Zhang N, Deuel TF (1999) Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors. Curr Opin Hematol 6:44-50
72. Zeng C, Toole BP, Kinney SD, Kuo JW, Stamenkovic I (1998) Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer 77(3):396-401
73. Soeda S, Shibata Y, Shimeno H (1997) Inhibitory effect of oversulfated fucoidan on tube formation by human vascular endothelial cells. Biol Pharm Bull 20(11):1131-1135
74. Soeda S, Sakaguchi S, Shimeno H, Nagamatsu A (1992) Fibrinolytic and coagulant activities of highly sulfated fucoidan. Biochem Pharmacol 43(8):1853-1858
75. Stein CA, La Rocca RV, Thomas R, McAtee N, Myers CE (1989) Suramin: an anticancer drug with a unique mechanism of action. J Clin Oncol 7:499-508
76. Gill JS, Windebank AJ (1998) Suramin induced ceramide accumulation leads to apoptotic cell death in dorsal root ganglion neurons. Cell Death Differ 5(10):876-883
77. Myers C, Cooper M, Stein C, La Rocca R, McClellan MW, Weiss G, Choyke P, Dawson N, Steinberg S, Uhrich MM, Cassidy J, Kohler DR, Trepel J, Linehan MW (1992) Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer. J Clin Oncol 10:881-889
78. Mauray S, Sternberg C, Theveniaux J, Millet J, Sinquin C, Tapon-Bretaudiere J, Fischer AM (1995) Venous antithrombotic and anticoagulant activities of a fucoidan fraction. Thromb Haemost 74:1280-1285